Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/22/24 16:30 | 5/20/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Lucera Erick | MA | O | EVP,CFO | 1 | S | -125 | 5.61 | 0 | -22 | 117 | D | |||||||||||||||
3/5/24 20:00 | 3/5/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | O'Neill Gilmore Neil | MA | DO | CEO | 2 | S.d | -795 | 9.42 | 0 | -84 | 327 | D | |||||||||||||||
3/5/24 19:54 | 3/4/24 | EDIT | Health | BioPrd | Biological Products, (No Diag | Mei Baisong | MA | O | SVP,CHIE | 2 | S.d | -229 | 9.31 | 0 | -25 | 142 | D | |||||||||||||||
12/7/23 16:30 | 12/5/23 | EDIT | Health | BioPrd | Biological Products, (No Diag | Eaton Bruce | MA | O | EVP,CBO, | 12 | S.d | -62 | 9.43 | 0 | -7 | 78 | D | |||||||||||||||
5/15/23 16:30 | 5/11/23 | EDIT | Health | BioPrd | Biological Products, (No Diag | Robertson Michelle | MA | O | EVP,CFO | 3 | S.d | -52 | 9.68 | 0 | -5 | 108 | D | |||||||||||||||
2/15/23 16:30 | 2/13/23 | EDIT | Health | BioPrd | Biological Products, (No Diag | Shearman Mark S | MA | O | EVP,Chie | 1 | S | -27 | 9.67 | 0 | -3 | 66 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |